81% of Organizations Plan to Add or Improve Employee Benefits This Year to Better Recruit and Retain Employees, According to New Lively Market Research Survey
Lively, Inc., a top-rated health and lifestyle benefits platform* known for launching the modern Health Savings Account (HSA), today announces the release of its Employee Benefits Market Check report. The report presents data and insights around employee benefits decision making gathered from 250 US-based HR and benefits decision makers, collected in collaboration with CITE research. Overall, the report found that employee experience, feedback, and ease-of-use matters above all else when benefits leaders are deciding when to select or renew with benefits providers.
"Employee benefits are a critical decision for companies and impact their goals and bottom line. They go far beyond health insurance, as the right package of flexible benefits enables employees to afford everyday expenses, plan for the future, and counter financial stress," said Alex Cyriac, co-founder and CEO of Lively.
The report found that:
81% of organizations are adding or improving benefits in the next year to support employee recruitment and retention.
One-in-four-organizations plan to add wellness benefits, bonuses, and emergency savings accounts in the next year, and one-in-five plan to add Lifestyle Spending Accounts, pet insurance, and professional development.
Employee feedback, over cost, is the chief driver of choosing and switching benefits providers, with four-in-ten benefits leaders saying employee complaints are the main catalyst to look for a new provider.
Ease of use for employees is the most important factor in choosing a benefits provider according to one-in-three HR leaders, but also the top area where providers fall short.
"A company's choice of benefits providers matters when it comes to impacting employee happiness, recruitment, and retention. Providing employees with flexible benefits that are easy-to-use and meet their needs, such as Health Savings Accounts and Lifestyle Spending Accounts, can go a long way to helping organizations meet their goals," said Shobin Uralil, co-founder and COO of Lively.
Lively is the health and lifestyle benefits platform that works the first time, every time. Our solutions are designed to take the guesswork out of managing benefits and drive efficiency for you and your teams. Our innovative platform is grounded by your everyday needs and circumstances. By combining robust features with unparalleled service, we make maximizing your benefits as simple as it should be.
Lively currently offers HSA, FSA, HRA, COBRA, Direct Bill, Commuter, Lifestyle Spending Accounts, and Medical Travel Accounts.
*Lively's HSA is top-rated according to Morningstar's 2023 Health Savings Account Landscape, G2, Trustpilot, and Lively's Customer Satisfaction survey.
Full Sail University's Annual Hall of Fame week kicked off with "Hall of Game." This esports event welcomed students and alumni to compete in popular titles including Call of Duty, Rocket League, and Super Smash Bros. Through Full Sail's partnership...
TIER IV, a pioneer in developing open-source software for autonomous driving (AD) systems, is set to launch a unique robotaxi service in November 2024. Initially targeting areas and times that conventional taxi operators struggle to serve, the...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...
SUNRATE, an intelligent global payment and treasury management platform today announced it has joined Mastercard Priceless Planet Coalition in support of fighting climate change through funding the restoration of 100 million trees. This announcement...
The advanced laser and plasma solution provider from Taiwan, E&R Engineering Corp., is confirmed to attend the feast in Semiconductor industry, Semicon SEA 2024, held in Kuala Lumpur, Malaysia. With the 30-year dedication in the semiconductor...
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...